Zobrazeno 1 - 10
of 189
pro vyhledávání: '"Lisa L. Wood"'
Autor:
Angie Secrest, Rafat Abonour, Michael J. Robertson, Kenneth Cornetta, R. Matthew Strother, Steven Messina-Graham, Jennifer E. Schwartz, David R. Jones, Lisa L. Wood, Shivani Srivastava, Hal E. Broxmeyer, Sherif S. Farag
Publikováno v:
Stem Cells and Development. 22:1007-1015
Delayed engraftment is a significant limitation of umbilical cord blood (UCB) transplantation due to low stem cell numbers. Inhibition of dipeptidyl peptidase (DPP)-4 enhanced engraftment in murine transplants. We evaluated the feasibility of systemi
Autor:
Patrick O. Monahan, J K Austin, C L Decker, Betsy L. Fife, Lisa L. Wood, Rafat Abonour, Mary L. Spath
Publikováno v:
Bone Marrow Transplantation. 48:135-140
Few studies have examined the effect of parental BMT on the family and less is known regarding the impact on children. The purpose of this prospective study was to increase understanding of children's adaptation to the stress of parental BMT across a
Autor:
Michael J. Robertson, Iftekhar Kalsekar, Craig Vargo, Christopher A. Fausel, Shivani Srivastava, Kenneth Cornetta, Patrick J. Kiel, Sherif S. Farag, Jennifer E. Schwartz, Cheryl K. Sullivan, Sahar Abdelqader, Lisa L. Wood, Rafat Abonour, Robert P. Nelson, John Baute, Lindsay Rosenbeck
Publikováno v:
Biology of Blood and Marrow Transplantation. 17:916-922
Methotrexate (MTX) is a standard agent used in combination with calcineurin inhibitors for graft-versus-host disease (GVHD) prophylaxis in patients undergoing allogeneic hematopoietic cell (HCT) transplantation. We retrospectively compared the incide
Autor:
Rafat Abonour, Cheryl K. Sullivan, John Baute, Jennifer E. Schwartz, Michael J. Robertson, Lisa L. Wood, David R. Jones, Robert P. Nelson, Angie Secrest, Elizabeth Cox, Sherif S. Farag, K Kane, Shivani Srivastava
Publikováno v:
Leukemia. 25:599-605
We conducted a phase I trial to determine the maximum tolerated dose (MTD) of clofarabine with high-dose busulfan followed by allogeneic stem cell transplantation (SCT) in patients with high-risk and refractory acute leukemia. Patients received intra
Publikováno v:
Bone Marrow Transplantation. 43:959-966
This study examined the course of adaptation as indicated by the level of emotional distress for family caregivers of adult BM recipients across the acute phase of the transplant trajectory. Factors influencing caregivers' adaptation that could be po
Autor:
Rafat Abonour, Constantin T. Yiannoutsos, Lisa L. Wood, Rafat Ansari, William B. Fisher, Attaya Suvannasankha, Beth E. Juliar, Gina G. Smith, Larry D. Cripe, Christopher A. Fausel
Publikováno v:
The Oncologist. 12:99-106
Thalidomide has direct antimyeloma and immunomodulatory effects. In addition, both thalidomide and metronomic chemotherapy inhibit angiogenesis. The synergy of such a combination may decrease toxicity while maintaining efficacy. The Hoosier Oncology
Autor:
Lisa L. Wood, Mohan V. Bala, Bernie J. O'Brien, Gary A. Zarkin, Edward C. Norton, Amiram Gafni
Publikováno v:
Journal of Clinical Epidemiology. 52:1047-1053
The standard gamble method, as currently recommended for use in health care program evaluation, provides an individual's preference score or "utility weight" for living in a given health state for the rest of the individual's life. Many researchers i
Publikováno v:
Resource and Energy Economics. 20:287-301
In this paper we use conjoint analysis to predict participation intentions for an optional energy service offered by Niagara Mohawk Power Corporation (NMPC). In contrast to conjoint studies that use ordinary least squares regression to estimate a uti
Autor:
Mohan V. Bala, Amiram Gafni, Lisa L. Wood, Edward C. Norton, Gary A. Zarkin, Bernie J. O'Brien
Publikováno v:
Journal of Clinical Epidemiology. 51:667-676
Quality-adjusted life-years (QALYs) and willingness to pay (WTP) are two preference-based measures of health-related outcomes. In this article, we compare these two measures in eliciting individuals' preferences for health outcomes associated with sh
Autor:
Kit N. Simpson, Charles L. Bennett, Lisa L. Wood, Michael N. Dohn, Mohan V. Bala, Gary A. Zarkin
Publikováno v:
PharmacoEconomics. 9:525-534
Pneumocystis carinii pneumonia (PCP) is the most common severe opportunistic infection, and one of the most costly, among people with AIDS. Over 50% of patients experience toxic effects of the major anti-PCP medications- cotrimoxazole (trimethoprim-s